), 300 °C (hold 2 min). Helium was used as carrier gas and EtOAc was used as solvent. , λ = 254 nm, injection vol. = 2 µL. Reaction products were quantified at 254 nm from the peak areas on the basis of standard curves with reference compounds. The ATase from Pseudomonas protegens (PpATaseCH) was overexpressed in E. coli BL21 (DE3) as described previously and used as cell-free extract preparations.
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Screening Procedure
Amine acceptor 1a-k (0.01 mmol, 10 mM final concentration) was suspended in potassium phosphate buffer (100 mM, pH 7.5). Then, cell-free extract of recombinant ATase (0.066 U) was added to the reaction mixture. The bioacylation was started by addition of the donor at the following final concentrations: DAPG (15 mM), IPEA (100 mM), PA (15 mM). DAPG was dissolved in DMSO (100 μL) to improve its solubility in buffer (10 vol % final concentration). The reaction mixture was shaken for 18 h at 35 ˚C and 750 rpm in an orbital shaker. Reactions were quenched by addition of acetonitrile (1 mL). The precipitated protein was removed by centrifugation (20 min, 14,000 rpm) and the supernatant was subjected to HPLC for determination of conversions. As a negative control, reactions without enzyme were performed.
Semi-preparative-scale Friedel-Crafts bioacetylation of amines
Amine (10 mM final concentration) was dissolved in potassium phosphate buffer (100 mM, pH 7.5) in a shaking flask. Cell-free extract containing the PpATaseCH (2.5 mL, 
Activity Assay
ATase-batch activities were measured on a Thermo Scientific Genesys 10 UV Scanning UV/Vis spectrophotometer according to a modified procedure from literature. , λ = 595 nm)] and specific activities were determined as units per mg protein.
Scheme S1. Reaction scheme of assay.
Purification of PpATaseCH
Purification of the PpATaseCH was achieved by size-exclusion chromatography with a Superdex 200 16/600 HiLoad-column. The column was initially washed with water, followed by conditioning (potassium phosphate buffer, 50 mM, pH 7.5, 100 mM NaCl). The cell-free extract (4 mL ≡ 0.57 g wet cells) was filtered (0.45 μm) prior to loading onto the column. The
PpATaseCH eluted after ~66 min with a flow-rate of 0.75 mL min -1 and the size of the protein (~98 kDa) was determined by comparison to a GelFiltration standard (BioRad). The purity of the PpATaseCH-fractions was estimated by SDS-PAGE ( Figure S1 ). All enzyme-containing fractions (10 × 500 µL) were combined and concentrated to approximately 2.5 mL with a Vivaspin column (MWCO 30,000). NaCl was removed by filtration through a PD-10-desalting column (final buffer = potassium phosphate buffer, 50 mM, pH 7.5) and the enzyme solution was concentrated again. Initial rates and protein concentrations were measured to determine the batch activity. In total, 13.1 mg of purified enzyme (0.1 U mg -1 ) was obtained from 0.57 g wet cells.
S5 Figure S1 . SDS-PAGE analysis of the PpATaseCH after purification via size-exclusion chromatography. Cellfree extract (M), flow-through (lanes 1-3; 5-9) and purified fractions of PpATaseCH (lane 4). 
Chemical Synthesis -General Procedure for Synthesis of Reference Compounds
In a round-bottomed flask, a mixture of a suitable amine (1 mmol) and vinyl acetate (1 mL, 9.2 mmol) was stirred at room temperature for 24 h. The progression of the reaction was monitored by TLC. Crude reaction mixture was concentrated in vacuo and purified by column chromatography on silica gel (hexane/ethyl acetate) to afford corresponding acetamides. Figure S10 . MS of compound 2a isolated from the preparative scale bioacylation.
N-phenylacetamide (2e)
N-phenylacetamide was purchased from Sigma-Aldrich. N-phenylacetamide isolated after biotransformation: 
N-(4-chlorophenyl)acetamide (2f)
N-(4-chlorophenyl)acetamide was chemically obtained as a white solid with 28 % product yield. 
N-(4-isopropylphenyl)acetamide (2g)
N-(4-isopropylphenyl)acetamide was chemically obtained as a white solid with 95 % product yield. 
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N-(2-ethylphenyl)acetamide (2j)
N- (2-ethylphenyl) 
